Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02480634
What this trial is testing

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBone Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 280
Testing effectiveness (Phase 2)UnknownNCT04872634
What this trial is testing

Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Who this might be right for
Non-small Cell Lung Cancer
NKMAX Co., Ltd. 24
Not applicableLooking for participantsNCT07809763
What this trial is testing

Wireless Wearable Home Prehabilitation for Older Adults With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)RehabilitationThoracic Surgery+1 more
West China Hospital 196
Testing effectiveness (Phase 2)Looking for participantsNCT05284539
What this trial is testing

Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 760
Large-scale testing (Phase 3)UnknownNCT01977209
What this trial is testing

Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 204
Not applicableStudy completedNCT03727477
What this trial is testing

Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib

Who this might be right for
Non-small Cell Lung Cancer MetastaticALK Gene Rearrangement PositiveROS-1 Gene Rearrangement Positive
Intergroupe Francophone de Cancerologie Thoracique 291
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06250777
What this trial is testing

Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 27
Not applicableUnknownNCT03701607
What this trial is testing

Effect of Chemotherapy on PD-L1 in NSCLC

Who this might be right for
ChemotherapyImmunotherapyPD-L1
Baodong Qin 30
Testing effectiveness (Phase 2)Study completedNCT01514877
What this trial is testing

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04180501
What this trial is testing

SRS Sequential Sindilimab in Brain Metastasis of NSLSC

Who this might be right for
NSCLC Stage IVBrain MetastasesSRS+1 more
Xiaorong Dong 25
Large-scale testing (Phase 3)Looking for participantsNCT06956001
What this trial is testing

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

Who this might be right for
EGFRNSCLC (Advanced Non-small Cell Lung Cancer)
Allist Pharmaceuticals, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT01752400
What this trial is testing

AUY922 for Advanced ALK-positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Massachusetts General Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT05313009
What this trial is testing

Tarlox and Sotorasib in Patients With KRAS G12C Mutations

Who this might be right for
Non-Small Cell Lung Cancer
Medical University of South Carolina 5
Testing effectiveness (Phase 2)Study completedNCT00653939
What this trial is testing

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

Who this might be right for
Tumors
Mateon Therapeutics 63
Large-scale testing (Phase 3)Active Not RecruitingNCT04536675
What this trial is testing

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

Who this might be right for
Chronic Obstructive Pulmonary DiseaseNon Small Cell Lung Cancer
Samsung Medical Center 204
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03844464
What this trial is testing

Safety and Efficacy of Lorbrena

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 1,290
Testing effectiveness (Phase 2)UnknownNCT02824952
What this trial is testing

Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC

Who this might be right for
Lung Cancer, Non-small Cell
Shaare Zedek Medical Center 40
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Study completedNCT00621049
What this trial is testing

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
SCRI Development Innovations, LLC 112
Next Page